Bio-Medical Applications Of North Carolina Inc Charlotte, NC - 28273

Bio-Medical Applications Of North Carolina Inc is categorized under Kidney Dialysis Centers in Charlotte, NC .

Bio-Medical Applications Of North Carolina Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.

If you are seeking more information, feel free to contact Dawn Lawson at the company’s branch by writing to 7901 England St, Charlotte, North Carolina NC 28273 or by phoning (704) 552-9102. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bio-Medical Applications Of North Carolina Inc
Contact Person: Dawn Lawson
Address: 7901 England St, Charlotte, North Carolina 28273
Phone Number: (704) 552-9102
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 621492
Share This Business:

Bio-Medical Applications Of North Carolina Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Dawn Lawson for inquiries that concern Bio-Medical Applications Of North Carolina Inc by calling the company number (704) 552-9102, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of North Carolina Inc can be found at the coordinates 35.132679,-80.880902 as well as the street address 7901 England St in Charlotte, North Carolina 28273.

For its online presence, you may visit Bio-Medical Applications Of North Carolina Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.